Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Pathol Oncol Res ; 26(4): 2401-2407, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32556889

ABSTRACT

Malignancies are still responsible for a large share of lethalities. Macroscopical evaluation of the surgical resection margins is uncertain. Big data based imaging approaches have emerged in the recent decade (mass spectrometry, two-photon microscopy, infrared and Raman spectroscopy). Indocianine green labelled MS is the most common approach, however, label free mid-infrared imaging is more promising for future practical application. We aimed to identify and separate different transformed (A-375, HT-29) and non-transformed (CCD986SK) cell lines by a label-free infrared spectroscopy method. Our approach applied a novel set-up for label-free mid-infrared range classification method. Transflection spectroscopy was used on aluminium coated glass slides. Both whole range spectra (4000-648 cm-1) and hypersensitive fingerprint regions (1800-648 cm-1) were tested on the imaged areas of cell lines fixed in ethanol. Non-cell spectra were possible to be excluded based on mean transmission values being above 90%. Feasibility of a mean transmission based spectra filtering method with principal component analysis and linear discriminant analysis was shown to separate cell lines representing different tissue types. Fingerprint region resulted the best separation of cell lines spectra with accuracy of 99.84% at 70-75 mean transmittance range. Our approach in vitro was able to separate unique cell lines representing different tissues of origin. Proper data handling and spectra processing are key steps to achieve the adaptation of this dye-free technique for intraoperative surgery. Further studies are urgently needed to test this novel, marker-free approach.


Subject(s)
Cell Separation/methods , Neoplasms , Optical Imaging/methods , Spectrophotometry, Infrared/methods , Cell Line, Tumor , Humans
2.
Eur J Clin Nutr ; 70(1): 91-6, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26105108

ABSTRACT

BACKGROUND/OBJECTIVES: The daily dietary intake of selenium (Se), an essential trace element, is still low in Sweden in spite of decades of nutritional information campaigns and the effect of this on the public health is presently not well known. The objective of this study was to determine the serum Se levels in an elderly Swedish population and to analyze whether a low Se status had any influence on mortality. SUBJECTS/METHODS: Six-hundred sixty-eight (n=668) elderly participants were invited from a municipality and evaluated in an observational study. Individuals were followed for 6.8 years and Se levels were re-evaluated in 98 individuals after 48 months. Clinical examination of all individuals included functional classification, echocardiography, electrocardiogram and serum Se measurement. All mortality was registered and endpoints of mortality were assessed by Kaplan-Meier plots, and Cox proportional hazard ratios adjusted for potential confounding factors were calculated. RESULTS: The mean serum Se level of the study population (n=668) was 67.1 µg/l, corresponding to relatively low Se intake. After adjustment for male gender, smoking, ischemic heart disease, diabetes, chronic obstructive pulmonary disease and impaired heart function, persons with serum Se in the lowest quartile had 43% (95% confidence interval (CI): 1.02-2.00) and 56% (95% CI: 1.03-2.36) increased risk for all-cause and cardiovascular mortality, respectively. The result was not driven by inflammatory effects on Se concentration in serum. CONCLUSION: The mean serum Se concentration in an elderly Swedish population was 67.1 µg/l, which is below the physiological saturation level for several selenoprotein enzymes. This result may suggest the value of modest Se supplementation in order to improve the health of the Swedish population.


Subject(s)
Cardiovascular Diseases/mortality , Deficiency Diseases/complications , Nutritional Status , Selenium/blood , Trace Elements/blood , Aged , Aged, 80 and over , Cardiovascular Diseases/blood , Cause of Death , Deficiency Diseases/blood , Female , Humans , Male , Proportional Hazards Models , Risk , Sweden/epidemiology
3.
Dis Esophagus ; 26(8): 853-8, 2013.
Article in English | MEDLINE | ID: mdl-22882570

ABSTRACT

One-lung ventilation (OLV) is applied during esophagectomy to improve exposure during the thoracic part of the operation. Collapse of lung tissue, shunting of pulmonary blood flow, and changes in alveolar oxygenation during and after OLV may possibly induce an ischemia-reperfusion response in the lung, which may affect the pulmonary endothelium. Such a reaction might thereby contribute to the frequently occurring respiratory complications among these patients. In this small trial, 30 patients were randomized to either OLV (n= 16) or two-lung ventilation (TLV, n= 14) during esophagectomy. Central venous and arterial plasma samples were taken before and after OLV/TLV for analysis of nitrite and a metabolite of nitric oxide (NO), and also during the 1st, 2nd, 3rd, and 10th postoperative day for analysis of endothelin, another endothelium-derived vasoactive mediator. Lung biopsies were taken before and after OLV or TLV, and analyzed regarding immunofluorescence for isoform of NO synthase, a protein upregulated during inflammatory response and also vascular congestion. No changes in lung isoform of NO synthase immunofluorescence or vascular congestion were registered after neither OLV nor TLV. Plasma nitrite and endothelin levels were similar in the two study groups. We conclude that OLV does not seem to have any influence on key regulators of pulmonary vascular tone and inflammation, i.e. NO and endothelin. From this perspective, OLV seems to be a safe method, which defends its clinical position to facilitate surgical exposure during thoracoabdominal esophagectomy.


Subject(s)
Endothelin-1/metabolism , Esophagectomy/methods , Lung Injury/metabolism , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide/metabolism , One-Lung Ventilation/methods , Reperfusion Injury/metabolism , Adenocarcinoma/surgery , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Biomarkers/metabolism , Carcinoma, Squamous Cell/surgery , Cohort Studies , Esophageal Neoplasms/surgery , Esophageal Squamous Cell Carcinoma , Female , Humans , Lung/blood supply , Lung/metabolism , Lung Injury/etiology , Male , Middle Aged , One-Lung Ventilation/adverse effects , Reperfusion Injury/etiology , Respiration, Artificial/methods
4.
Int J Immunopathol Pharmacol ; 20(1): 17-24, 2007.
Article in English | MEDLINE | ID: mdl-17346424

ABSTRACT

Hepatocellular Carcinoma (HCC) is one of the most frequent cancers worldwide, however, prognosis remains poor following its discovery. We investigate the Thioredoxin superfamily of proteins as diagnostic markers for HCC. Furthermore, we delineate possible roles of the endoplasmic reticulum member of the superfamily, ERdj5, in carcinogenesis. Using antibodies against Thioredoxin 1, Thioredoxin Reductase 1 and ERdj5, we performed immunohistochemistry on paraffin embedded liver biopsy sections from HCC patients. All three redox proteins exhibited elevated expression levels in tumor tissue compared to internal control, with ERdj5 showing a remarkable 3-fold increase. In vitro cell viability experiments using Hepatocellular Carcinoma HuH7 cells treated with ERdj5 small interfering RNA showed that ERdj5 knockdown cells exhibited less resistance to Doxorubicin (chemotherapy drug), but more resistance to Tunicamycin (Endoplasmic Stress inducer), compared to control cells. In conclusion, we introduce members of the Thioredoxin superfamily as possible immunohistochemical markers in the diagnostics of hepatocellular carcinoma and indicate a potential defensive role for ERdj5 in chemotherapeutic drug resistance.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Liver Neoplasms/metabolism , Thioredoxins/biosynthesis , Cell Line , Cell Line, Tumor , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Doxorubicin/therapeutic use , Drug Resistance, Neoplasm , Endoplasmic Reticulum/physiology , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , HSP40 Heat-Shock Proteins , Humans , Immunohistochemistry , Molecular Chaperones/immunology , Paraffin Embedding , Pilot Projects , RNA/biosynthesis , RNA/isolation & purification , RNA, Small Interfering/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Stress, Physiological/chemically induced , Stress, Physiological/metabolism , Tunicamycin/pharmacology
5.
J Hepatol ; 35(2): 259-64, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11580149

ABSTRACT

BACKGROUND/AIMS: Thioredoxin reductase, a redox active enzyme, is induced in several tumors. This study focuses on the presence of and subcellular localisation of thioredoxin reductase in a tumor model where neoplastic lesions are selected by their resistance to the toxic effects of the promotor. METHODS: Liver nodules produced by intermittent feeding of 2-acetylaminofluorene to male Wistar rats were analyzed for thioredoxin reductase (TrxR) activity and mRNA. RESULTS: This activity was increased 3.5-fold in the cytosol but decreased 60% in the mitochondrial fraction compared to the liver of age-matched untreated animals. Only traces of activity were observed in the microsomal, plasma membrane and nuclear fractions from normal liver or nodules. The level of TrxR mRNA was 3-fold higher in nodules than in normal rat liver. Furthermore, the total level of SH groups in homogenates was 2-fold higher in the case of the nodules. CONCLUSIONS: These findings indicate that the thioredoxin system makes an important contribution to the resistant phenotype of the neoplastic liver cell, which conveys a growth advantage of significance for tumor progression.


Subject(s)
Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Neoplasm/genetics , RNA, Neoplasm/metabolism , Thioredoxin-Disulfide Reductase/genetics , Thioredoxin-Disulfide Reductase/metabolism , 2-Acetylaminofluorene/toxicity , Animals , Cytosol/metabolism , Drug Resistance/genetics , Liver Neoplasms, Experimental/chemically induced , Male , Promoter Regions, Genetic , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Subcellular Fractions/metabolism
6.
Eur J Biochem ; 268(5): 1486-90, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11231302

ABSTRACT

Lipoamide dehydrogenase belongs to a family of pyridine nucleotide disulfide oxidoreductases and is ubiquitous in aerobic organisms. This enzyme also reduces ubiquinone (the only endogenously synthesized lipid-soluble antioxidant) to ubiquinol, the form in which it functions as an antioxidant. The reduction of ubiquinone was linear with time and exhibited turnover numbers of 5 and 1.2 min(-1) in the presence and absence of zinc, respectively. The reaction was stimulated by zinc and cadmium but not by the other divalent ions tested. The zinc/cadmium-dependent stimulation of the reaction increased rapidly and linearly up to a concentration of 0.1 mM and was even further increased at 0.5 mM. At pH 6, the activity was three times higher than at physiological pH. Alteration of the NADPH : NADP(+) ratio revealed that the reaction is inhibited by higher concentrations of the oxidized cofactors. FAD reduced ubiquinone in a dose-dependent manner at a considerably lower rate, suggesting that the reduction of ubiquinone by lipoamide dehydrogenase involves the FAD moiety of the enzyme.


Subject(s)
Antioxidants/metabolism , Coenzymes/metabolism , Dihydrolipoamide Dehydrogenase/metabolism , Ubiquinone/analogs & derivatives , Ubiquinone/metabolism , Animals , Antioxidants/chemistry , Cadmium/metabolism , Cations, Divalent/metabolism , Chromatography, High Pressure Liquid , Flavin-Adenine Dinucleotide/metabolism , Heart , Hydrogen-Ion Concentration , Kinetics , Lipid Peroxidation , NAD/metabolism , NADP/metabolism , Oxidation-Reduction , Swine , Ubiquinone/chemistry , Zinc/metabolism
7.
Differentiation ; 66(4-5): 181-8, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11269944

ABSTRACT

Malignant mesothelioma is a tumour originating from mesothelial cells, and it exhibits epithelial, fibrous, or biphasic differentiation. This tumour is highly resistant to therapy, and presence of a sarcomatous growth pattern has been associated with worse prognosis. A mesothelioma cell line with retained ability to differentiate into either epithelial or fibroblast-like phenotype was subjected to subtractive hybridisation in order to identify the genes coupled to tumour cell differentiation. Nine genes were found to be selectively overexpressed in the epithelial sub-line, compared to only two genes in the fibroblast-like phenotype. This may support the idea that the sarcomatous phenotype represents a less differentiated tumour. One of the genes that is differentially expressed by the epithelial cells was thioredoxin, a small redox-active protein associated with cell-growth and differentiation. This overexpression was accompanied by increased protein levels both intracellularly and in the medium. Thioredoxin is reduced by the selenoprotein thioredoxin reductase and NADPH. The activity of this enzyme was high in both cell sub-lines but induced 2-fold in the epithelially-differentiated cells. Overexpression of thioredoxin might be a factor behind the poor prognosis and reduced responsiveness to therapy of mesotheliomas. Epithelial differentiation in this cell line has previously been linked to increased synthesis of heparan sulphate proteoglycans. The possible formation of complexes including thioredoxin, thioredoxin reductase, and heparan sulphate proteoglycans might play a role in the local control of cell growth and differentiation.


Subject(s)
Gene Expression Regulation, Neoplastic , Mesothelioma/genetics , Mesothelioma/pathology , Thioredoxins/genetics , Blotting, Western , Cell Differentiation/genetics , Cloning, Molecular , Epithelial Cells/metabolism , Epithelial Cells/pathology , Epithelial Cells/physiology , Humans , Mesothelioma/metabolism , Nucleic Acid Hybridization , Polymerase Chain Reaction , Thioredoxin-Disulfide Reductase/metabolism , Thioredoxins/biosynthesis , Up-Regulation
8.
FEBS Lett ; 448(1): 190-2, 1999 Apr 01.
Article in English | MEDLINE | ID: mdl-10217438

ABSTRACT

Ubiquinol is an endogenously synthesized lipid-soluble antioxidant. Regeneration of ubiquinol from the oxidized form is essential to the maintenance of its antioxidant function. We demonstrated that lipoamide dehydrogenase can reduce ubiquinone to ubiquinol. Zinc increased the rate of the NADPH-dependent reduction more than 10-fold. The concentration ubiquinone resulting in the half-maximal rate of reduction was approximately 5 microM in the presence and 4 microM in the absence of zinc. These data may explain how ubiquinone is reduced to the active antioxidant ubiquinol, which plays such an important role in protecting against oxidative stress and lipid peroxidation.


Subject(s)
Dihydrolipoamide Dehydrogenase/metabolism , Ubiquinone/metabolism , Zinc , NAD/metabolism , NADP/metabolism , Oxidation-Reduction
9.
Free Radic Biol Med ; 24(7-8): 1176-86, 1998 May.
Article in English | MEDLINE | ID: mdl-9626572

ABSTRACT

Thioredoxin (Trx) and glutaredoxin (Grx) are both multifunctional redox-active proteins. In this study, Grx was identified in human plasma by immunoaffinity purification. The affinity-purified material from human plasma displayed a band of 12 kDa identical to recombinant human Grx by Western blotting and its glutathione-dependent reducing activity of beta-hydroxyethyl disulfide. Competitive enzyme-linked immunosorbent assays (ELISA) showed that plasma levels (mean +/- SD) of Grx and Trx in healthy volunteers (n = 41) were 456 +/- 284 ng/ml and 28.5 +/- 12.6 ng/ml, respectively. In cardiac surgical patients (n = 17), plasma Grx levels did not significantly change during cardiopulmonary bypass (CPB). In contrast, Trx levels in arterial plasma measured by sandwich ELISA and corrected for hemolysis were elevated during reperfusion of the postcardioplegic heart (p = .0001 at maximum), whereas by competitive ELISA Trx increased during surgical preparation for CPB, but decreased during CPB. When recombinant Trx was oxidized, immunoreactive Trx levels were decreased by competitive ELISA but not changed by sandwich ELISA. These results suggest that oxidized Trx is released into plasma during CPB. There was no significant difference in Trx and Grx levels between arterial and intracoronarial plasma samples, indicating no specific release by the post-cardioplegic heart. Trx and Grx may be important components in the plasma defense against oxidative stress.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Oxidoreductases/blood , Protein Disulfide Reductase (Glutathione) , Thioredoxins/blood , Adult , Aged , Aged, 80 and over , Blotting, Western , Cardiopulmonary Bypass/adverse effects , Case-Control Studies , Disulfides/metabolism , Enzyme-Linked Immunosorbent Assay , Ethanol/analogs & derivatives , Ethanol/metabolism , Female , Glutaredoxins , Hemolysis , Humans , In Vitro Techniques , Male , Middle Aged , Oxidation-Reduction , Oxidative Stress
10.
Biomed Environ Sci ; 10(2-3): 271-9, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9315320

ABSTRACT

Thioredoxin (Trx) is a small ubiquitous dithiol protein which together with the FAD-containing enzyme thioredoxin reductase (TR) and NADPH (the Trx system) is a hydrogen donor for ribonucleotide reductase essential for DNA synthesis and a general protein disulfide reductase involved in redox regulation. Selenite, selenodiglutathione (GS-Se-SG) and selenocystine are efficiently reduced by thioredoxins and also directly by NADPH and mammalian TR but not by the E. coli enzyme. Incubation of selenite or GS-Se-SG with the Trx system or with mammalian TR results in a rapid formation of selenide, which by redox cycling with oxygen may cause a large non-stoichiometric oxidation of NADPH. Selenocystine is efficiently reduced into two molecules of the selenol amino acid selenocysteine by mammalian TR with a K(m)-value (6 mumol.L-1) and a high turnover number (kappa cat 3200 min-1) almost identical to the natural substrate Trx-S2. TR also directly reduces lipid hydroperoxides and this peroxidase reaction is strongly stimulated by the presence of catalytic amounts of free selenocysteine. Glutaredoxin (Grx) which catalyzes GSH-dependent disulfide reduction also via a redox-active disulfide and Trx are both efficient electron donors to the human plasma glutathione peroxidase providing a mechanism by which human plasma glutathione peroxidase may reduce hydroperoxides in an environment almost free from glutathione. Selenate is reduced by Grx and Trx in the presence of GSH. The DNA-binding of the transcription factor AP-1 is strongly inhibited by GS-Se-SG and selenite. Furthermore, selenide formed by TR-mediated reduction of selenite and GS-Se-SG inhibits lipoxygenase and changes the electron spin resonance spectrum of the active site iron. Mammalian TR with two subunits of 57 kDa has recently been cloned and shown to be homologous to glutathione reductase. The rat enzyme contains a selenocysteine residue in a unique Cterminal position and a conserved SECIS sequence directing insertion of the selenocysteine. The discovery of selenocysteine in mammalian TR may explain the broad substrate specificity of the enzyme and the requirement of selenium for cell proliferation.


Subject(s)
Oxidoreductases , Proteins/metabolism , Selenium Compounds/metabolism , Thioredoxins/metabolism , Amino Acid Sequence , Glutaredoxins , Humans , In Vitro Techniques , Oxidation-Reduction , Thioredoxin-Disulfide Reductase/chemistry , Thioredoxin-Disulfide Reductase/metabolism
11.
Mol Immunol ; 34(10): 709-17, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9430198

ABSTRACT

Thioredoxin, a 12,000 mol. wt protein with two redox-active cysteine residues, together with thioredoxin reductase and NADPH, may reduce protein disulfides and thereby act as a molecular probe of their structure and reactivity. Interchain and intrachain disulfides are structural elements in all immunoglobulins and therefore potential substrates for the reduced thioredoxin, Trx(SH)2. It was investigated whether such disulfides are cleaved in human polyclonal IgG and IgG subclass myeloma proteins by both the human and the Escherichia coli thioredoxin systems. The reactions were monitored spectrophotometrically as oxidation of NADPH at 340 nm, and by following the kinetics of the cleavage patterns with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS PAGE). Human IgG was a substrate for both prokaryotic and eukaryotic Trx(SH)2, which directly reduced IgG disulfides in a time and dose-dependent manner. Stoichiometric analyses indicated near-complete reduction of mainly inter-heavy light chain and inter-heavy chain disulfides, and SDS PAGE corroborated that the buried intrachain disulfides were left intact. The kinetic studies showed that IgG1, IgG3 and IgG4 were readily reduced into heavy and light chains via the formation of half-molecules with slightly slower kinetics for IgG4. In sharp contrast, IgG2 was not cleaved at all, even with increased thioredoxin concentrations or reduction times. A small but significant NADPH consumption by IgG2 myeloma proteins suggested reduction of a labile interchain or surface-exposed mixed disulfide. Consistent results were obtained for several IgG myeloma proteins within each subclass. The structural and functional importance of interchain disulfides in immunoglobulins suggests physiological implications of the thioredoxin system.


Subject(s)
Disulfides/metabolism , Immunoglobulin G/metabolism , Myeloma Proteins/metabolism , NADP/metabolism , Thioredoxin-Disulfide Reductase/metabolism , Thioredoxins/metabolism , Electrophoresis, Polyacrylamide Gel , Escherichia coli/enzymology , Humans , Immunoglobulin Heavy Chains/metabolism , Immunoglobulin Light Chains/metabolism , Kinetics , Oxidation-Reduction , Proteins/analysis , Recombinant Proteins/metabolism , Spectrophotometry
12.
Cancer Res ; 56(19): 4407-12, 1996 Oct 01.
Article in English | MEDLINE | ID: mdl-8813134

ABSTRACT

Selenium compounds like selenite and selenate have strong inhibitory effects, particularly on mammalian tumor cell growth by unknown mechanisms. We found that the addition of sodium selenite and sodium selenate inhibited the growth of human 3B6 and BL41 lymphocytes. Selenite was more potent because 10 microM selenite produced a growth inhibitory effect similar to that of 250 microM selenate. The mechanism of action of selenite and selenate appears to be different. 3B6 and BL41 cells treated with selenite accumulated in the S-phase; however, selenate caused an accumulation of cells in G2. Selenite-mediated growth inhibition was irreversible, although the effects of selenate could be reversed. Selenite, in contrast to selenate, is efficiently reduced by the thioredoxin system (thioredoxin, thioredoxin reductase, and NADPH). At concentrations required to observe a similar effect on cell growth, the activity of thioredoxin reductase, recently shown to be a selenoprotein, increased in selenite-treated cells and decreased in selenate-treated cells. Ribonucleotide reductase activity was inhibited in an in vitro assay by selenite and selenodiglutathione but not by selenate. These results show that selenite and selenate use different mechanisms to inhibit cell growth.


Subject(s)
B-Lymphocytes/drug effects , Growth Inhibitors/pharmacology , Selenium Compounds/pharmacology , Sodium Selenite/pharmacology , Cell Cycle/drug effects , Cell Division/drug effects , Cell Line, Transformed , Humans , Ribonucleotide Reductases/metabolism , Selenic Acid , Thioredoxin-Disulfide Reductase/metabolism
13.
Biochemistry ; 35(26): 8511-6, 1996 Jul 02.
Article in English | MEDLINE | ID: mdl-8679612

ABSTRACT

Selenite and selenodiglutathione (GS-Se-SG) efficiently inhibited 5-lipoxygenase activity in sonicates of human monoclonal B-lymphocytes. The apparent IC50 of GS-Se-SG was 0.5 microM. The inhibitory effect of these compounds was observed within 10 min of incubation. In order to elucidate if the mechanism of inhibition by these compounds was result of direct interference with lipoxygenase or indirectly mediated by cellular factors, pure 15-lipoxygenase from soybeans was used as a model system for enzyme assays and electron spin resonance (ESR) measurements. Incubation of 15-lipoxygenase with a mixture of human placenta thioredoxin reductase (TR) or calf-thymus TR, selenite, and NADPH blocked the activity of the enzyme. Neither TR and NADPH nor selenite inhibited soybean lipoxygenase when incubated separately. These results suggest that selenite must be reduced to selenide in order to inhibit 5- and 15-lipoxygenase activities. Preincubation anaerobically of 15-lipoxygenase with chemically generated selenide (6 microM) resulted in a strong inhibition of activity, in assays with arachidonic acid in the presence of oxygen. In contrast, selenide exposed to air prior to preincubation did not inhibit the enzyme. Since selenide is known to be efficiently oxidized by oxygen and to form elemental selenium the results evidence that selenide was the inhibitor of lipoxygenase activity in the anaerobic preincubations. After incubation with TR, NADPH, and selenite or with chemically generated selenide, the ESR spectrum of 15-lipoxygenase changed: the dominant axial component with a peak at g = 6.1 decreased, and a rhombic form with a feature at g = 4.28 grew. The results suggest that selenide produced by the reduction of selenite reduces the active site iron to the ESR invisible state and changes the ligation geometry of the oxidized form.


Subject(s)
Iron/chemistry , Lipoxygenase Inhibitors/chemistry , NADP/chemistry , Selenium Compounds/pharmacology , Sodium Selenite/pharmacology , Thioredoxin-Disulfide Reductase/chemistry , Arachidonate 15-Lipoxygenase/metabolism , Arachidonate 5-Lipoxygenase/metabolism , B-Lymphocytes/enzymology , Binding Sites , Electron Spin Resonance Spectroscopy , Humans , Iron/metabolism , Selenic Acid
14.
FEBS Lett ; 368(1): 59-63, 1995 Jul 10.
Article in English | MEDLINE | ID: mdl-7615089

ABSTRACT

The binding of the transcription factor AP-1 to DNA has been shown to be modulated by redox control mechanisms. Selenite and selenodiglutathione (GS-Se-SG), inhibit mammalian cell growth and are efficient oxidants of reduced thioredoxin and reduced thioredoxin reductase. Here, we report that selenite and GS-Se-SG efficiently inhibited AP-1 DNA-binding in nuclear extracts from 3B6 lymphocytes. A GS-Se-SG concentration of 0.75 microM resulted in 50% inhibition of AP-1 DNA-binding, whereas the same effect was achieved with 7.5 microM selenite. Nuclear extracts prepared from human 3B6 lymphocytes exposed for 4 h to 10 microM selenite showed a 50% reduction of AP-1 binding. These data suggest that selenite and selenodiglutathione inactivate the AP-1 factor and provide a mechanism by which selenium compounds inhibit cell growth.


Subject(s)
DNA/metabolism , Glutathione/analogs & derivatives , Organoselenium Compounds/pharmacology , Sodium Selenite/pharmacology , Transcription Factor AP-1/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cell Division/drug effects , Cell Line, Transformed , DNA Probes , Glutathione/pharmacology , Humans , Lymphocytes/metabolism , Mice , Molecular Sequence Data , Oxidation-Reduction , Protein Binding/drug effects , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/metabolism
15.
J Biol Chem ; 270(20): 11761-4, 1995 May 19.
Article in English | MEDLINE | ID: mdl-7744824

ABSTRACT

Human placenta thioredoxin reductase (HP-TR) in the presence of NADPH-catalyzed reduction of (15S)-hydroperoxy-(5Z),(8Z),11(Z),13(E)-eicosatetraenoic acid ((15S)-HPETE) into the corresponding alcohol ((15S)-HETE). Incubation of 50 nM HP-TR and 0.5 mM NADPH with 300 microM 15-HPETE for 5 min resulted in formation of 16.5 microM 15-HETE. After 60 min, 74.7 microM 15-HPETE was reduced. The rate of the reduction of 15-HPETE by the HP-TR/NADPH peroxidase system was increased 8-fold by the presence of 2.5 microM selenocystine, a diselenide amino acid. In this case, 15-HPETE was catalytically reduced by the selenol amino acid, selenocysteine, generated from the diselenide by the HP-TR/NADPH system. To a smaller extent, selenodiglutathione or human thioredoxin also potentiated the reduction of 15-HPETE by HP-TR. Hydrogen peroxide and 15-HPETE were reduced at approximately the same rate by HP-TR, thioredoxin, and selenocystine. In contrast, t-butyl hydroperoxide was reduced at a 10-fold lower rate. Our data suggest two novel pathways for the reduction and detoxification of lipid hydroperoxides, hydrogen peroxide, and organic hydroperoxides, i.e. the human thioredoxin reductase-dependent pathway and a coupled reduction in the presence of selenols or selenide resulting from the reduction of selenocystine or selenodiglutathione.


Subject(s)
Cystine/analogs & derivatives , Glutathione Transferase/metabolism , Hydroxyeicosatetraenoic Acids/metabolism , Leukotrienes/metabolism , Lipid Peroxides/metabolism , Mitogen-Activated Protein Kinase Kinases , NADP/metabolism , Organoselenium Compounds/metabolism , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Thioredoxin-Disulfide Reductase/pharmacology , Catalysis , Cystine/metabolism , Glutathione/analogs & derivatives , Glutathione/pharmacology , Humans , Hydrogen Peroxide/metabolism , Lipid Peroxidation/drug effects , MAP Kinase Kinase 1 , Models, Biological , Organoselenium Compounds/pharmacology , Oxidation-Reduction , Peroxides/metabolism , Placenta/enzymology , Protein Serine-Threonine Kinases/chemistry , Protein-Tyrosine Kinases/chemistry , Selenocysteine/metabolism , Thioredoxins/pharmacology , tert-Butylhydroperoxide
16.
J Biol Chem ; 270(8): 3479-82, 1995 Feb 24.
Article in English | MEDLINE | ID: mdl-7876079

ABSTRACT

Human thioredoxin reductase is a dimeric enzyme that catalyzes reduction of the disulfide in oxidized thioredoxin by a mechanism involving transfer of electrons from NADPH via FAD to a redox-active disulfide. 1-Chloro-2,4-dinitrobenzene (DNCB) is an alkylating agent used for depleting intracellular GSH and also showing distinct immunomodulatory properties. We have discovered that low concentrations of DNCB completely inactivated human or bovine thioredoxin reductase, with a second order rate constant in excess of 200 M-1 s-1, which is almost 10,000-fold faster than alkylation of GSH. Total inactivation of 50 nM reduced thioredoxin reductase was obtained by 100 microM DNCB after 5 reductase was obtained by 100 microM DNCB after 5 min of incubation at 20 degrees C also in the presence of 1 mM GSH. The inhibition occurred with enzyme only in the presence of NADPH and persisted after removal of DNCB, suggesting alkylation of the active site nascent thiols as the mechanism of inactivation. Thioredoxin reductase modified by DNCB lacked reducing activity with oxidized thioredoxin, 5,5'-dithiobis-(2-nitrobenzoic acid), or sodium selenite. However, the DNCB-modified enzyme oxidized NADPH at a rate of 4.7 nmol/min/nmol of enzyme in the presence of atmospheric oxygen. This activity was not dependent on the presence of DNCB in solution and constituted a 34-fold increase of the inherent low NADPH oxidase activity of the native enzyme. DNCB is a specific inhibitor of mammalian thioredoxin reductase, which reacted 100-fold faster than glutathione reductase. The inactivation of the disulfide reducing activity of thioredoxin reductase and thioredoxin with a concomitant large increase of the NADPH oxidase activity producing reactive oxygen intermediates may mediate effects of DNCB on cells in vivo.


Subject(s)
Dinitrochlorobenzene/pharmacology , NADH, NADPH Oxidoreductases/biosynthesis , Thioredoxin-Disulfide Reductase/antagonists & inhibitors , Animals , Cattle , Enzyme Induction , Glutathione/metabolism , Humans , Kinetics , NADPH Oxidases , Thioredoxin-Disulfide Reductase/metabolism
19.
J Biol Chem ; 269(47): 29382-4, 1994 Nov 25.
Article in English | MEDLINE | ID: mdl-7961915

ABSTRACT

Human plasma glutathione peroxidase (GSH-Px) is a distinct extracellular selenoenzyme that detoxifies hydroperoxides when used with GSH in high (mM) non-physiological concentrations. We have discovered that NADPH and human thioredoxin reductase (TR) by itself or with thioredoxin (Trx) are efficient electron donors to this human plasma peroxidase. Incubation of 0.05 microM TR with 0.25 microM GSH-Px, in a system free from GSH, resulted in reduction of t-butyl hydroperoxide. Addition of Trx, 2.5 and 5 microM, respectively, further increased the rate of the reaction. These data were obtained using an assay measuring the oxidation of NADPH. A direct assay demonstrated the formation of cumyl alcohol from cumene hydroperoxide in this GSH-independent peroxidase reaction. Incubation of 0.25 microM GSH-Px with a low concentration of GSH (10 microM), representing the upper level in plasma, plus excess glutathione reductase and NADPH did not result in any reduction of t-butyl hydroperoxide. However, after addition of 2.5 microM human glutaredoxin, a linear peroxidase reaction started. The results suggest that extracellular TR, Trx, or glutaredoxin are reductants for the selenium-dependent peroxidase rather than GSH.


Subject(s)
Glutathione Peroxidase/metabolism , Oxidoreductases , Proteins/metabolism , Thioredoxins/metabolism , Electron Transport , Glutaredoxins , Glutathione Peroxidase/blood , Humans
20.
Biochemistry ; 32(37): 9701-8, 1993 Sep 21.
Article in English | MEDLINE | ID: mdl-8373774

ABSTRACT

A human thioredoxin cDNA was modified to optimize Escherichia coli expression and subcloned into the plasmid pACA, a vector for T7 RNA polymerase-directed expression. The substitution of structural (noncatalytic) half-cystines in human thioredoxin (hTrx) was made by site-directed mutagenesis. The recombinant wild-type (wt) hTrx and its mutant C61S, C72S, and C61S/C72S were expressed and purified to homogeneity. Characterization of the wt and mutant hTrx was done with respect to redox activity with thioredoxin reductase (TR), tryptophan fluorescence, and effects of incubation with GS-Se-SG, which is believed to be the major metabolite of inorganic selenium compounds in mammalian tissues. The Km and kcat of wild-type hTrx for human placenta thioredoxin reductase (HP-TR) at pH 7.0 were 2.0 microM and 2800 min-1, respectively. The mutant proteins C61S, C72S, and C61S/C72S had Km and kcat values similar to those of the wt thioredoxin. Tryptophan fluorescence measurements showed that the wt and mutant proteins had similar stability to a denaturing agent. Incubation of fully reduced thioredoxin with 0.1 molar equivalent of GS-Se-SG resulted in continued oxidation of SH groups. After 3.5 h only 0.5 of initially 4.6 SH groups/thioredoxin remained. With the oxidized protein, a pronounced lag phase in thioredoxin reductase-dependent insulin disulfide reduction was present. Disulfide-linked dimers of the protein were present. The results clearly showed that noncatalytic cysteine residues in hTrx were oxidized accompanied by dimerization and inactivation. The activities of the mutant proteins C72S and C61S/C72S were unchanged after 3 h of incubation with GS-Se-SG. No dimer appeared of the C72S thioredoxin.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Glutathione/analogs & derivatives , Organoselenium Compounds/chemistry , Thioredoxins/metabolism , Amino Acid Sequence , Base Sequence , Cysteine/chemistry , Cystine/chemistry , Glutathione/chemistry , Glutathione/metabolism , Humans , Kinetics , Molecular Sequence Data , NADP/metabolism , Oligodeoxyribonucleotides/chemistry , Organoselenium Compounds/metabolism , Oxidation-Reduction , Protein Denaturation , Recombinant Proteins , Thioredoxins/antagonists & inhibitors , Thioredoxins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...